世界の皮膚糸状菌性爪真菌症（DO）市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Dermatophytic Onychomycosis Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z1804 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、99ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥546,000 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥819,000 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,092,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査資料では、皮膚糸状菌性爪真菌症（DO）のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（経口薬、外用薬）、用途別市場規模（18歳以下、18〜50歳、50歳以上）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・皮膚糸状菌性爪真菌症（DO）の市場動向 ・企業の競争状況、市場シェア ・皮膚糸状菌性爪真菌症（DO）の種類別市場規模（経口薬、外用薬） ・皮膚糸状菌性爪真菌症（DO）の用途別市場規模（18歳以下、18〜50歳、50歳以上） ・皮膚糸状菌性爪真菌症（DO）の北米市場規模2016-2027（アメリカ、カナダ） ・皮膚糸状菌性爪真菌症（DO）のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・皮膚糸状菌性爪真菌症（DO）のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・皮膚糸状菌性爪真菌症（DO）の中南米市場規模2016-2027（メキシコ、ブラジル） ・皮膚糸状菌性爪真菌症（DO）の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Johnson & Johnson、GSK、Novartis、Pfizer、Bausch Health、Kaken Pharmaceutical、Galderma、Sanofi、Allergan、Merz Pharma、Xiuzheng Pharmaceutical、Letai、Qilu Pharmaceutical） ・結論

Dermatophytic onychomycosis is a fungal infection of the nail plate, nail bed, and, in some cases, the skin surrounding the nail plate. It is caused by yeast, dermatophytes, and molds; dermatophytes account for 90% of all cases. The fungus, especially Trichophyton rubrum, Trichophyton mentagrophytes, and Epidermophyton floccosum, infects the skin, hair, or nails. It is often perceived by people to be an active and contagious infection. Onychomycosis may persist or worsen if not treated. The fungi that cause onychomycosis exist in common sites such as floors, soil, socks, and shoes. Therapies for onychomycosis include debridement and drugs. Debridement is time consuming and minimally effective in eradicating the fungal infection. Systemic drug treatment is most effective in treating onychomycosis.
Factors such as the rising prevalence of dermatophytic onychomycosis, heavy investments to develop therapies, and frequent product innovations will aid in the steady growth of this market during the forecast period. An important factor that will impel the prospects for growth in this market is the augmented focus on combination therapies. Recently, it has been observed that a combination of topical and systemic treatment increases the cure rate when compared to individual therapies. Since combination therapies have improved clinical efficiency and are more cost-effective than terbinafine, they are increasingly being preferred over individual terbinafine-based therapies as they have a higher cure rate.

Market Analysis and Insights: Global Dermatophytic Onychomycosis Market
The global Dermatophytic Onychomycosis market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Dermatophytic Onychomycosis market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Dermatophytic Onychomycosis market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Dermatophytic Onychomycosis market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Dermatophytic Onychomycosis market.

Global Dermatophytic Onychomycosis Scope and Market Size
Dermatophytic Onychomycosis market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Dermatophytic Onychomycosis market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Oral Medicine
External Medicine

Segment by Application
Age Under 18
Age 18-50
Age Above 50

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Johnson & Johnson
GSK
Novartis
Pfizer
Bausch Health
Kaken Pharmaceutical
Galderma
Sanofi
Allergan
Pfizer
Bausch Health

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Dermatophytic Onychomycosis Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Oral Medicine
1.2.3 External Medicine
1.3 Market by Application
1.3.1 Global Dermatophytic Onychomycosis Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Age Under 18
1.3.3 Age 18-50
1.3.4 Age Above 50
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Dermatophytic Onychomycosis Market Perspective (2016-2027)
2.2 Dermatophytic Onychomycosis Growth Trends by Regions
2.2.1 Dermatophytic Onychomycosis Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Dermatophytic Onychomycosis Historic Market Share by Regions (2016-2021)
2.2.3 Dermatophytic Onychomycosis Forecasted Market Size by Regions (2022-2027)
2.3 Dermatophytic Onychomycosis Industry Dynamic
2.3.1 Dermatophytic Onychomycosis Market Trends
2.3.2 Dermatophytic Onychomycosis Market Drivers
2.3.3 Dermatophytic Onychomycosis Market Challenges
2.3.4 Dermatophytic Onychomycosis Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Dermatophytic Onychomycosis Players by Revenue
3.1.1 Global Top Dermatophytic Onychomycosis Players by Revenue (2016-2021)
3.1.2 Global Dermatophytic Onychomycosis Revenue Market Share by Players (2016-2021)
3.2 Global Dermatophytic Onychomycosis Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Dermatophytic Onychomycosis Revenue
3.4 Global Dermatophytic Onychomycosis Market Concentration Ratio
3.4.1 Global Dermatophytic Onychomycosis Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Dermatophytic Onychomycosis Revenue in 2020
3.5 Dermatophytic Onychomycosis Key Players Head office and Area Served
3.6 Key Players Dermatophytic Onychomycosis Product Solution and Service
3.7 Date of Enter into Dermatophytic Onychomycosis Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Dermatophytic Onychomycosis Breakdown Data by Type
4.1 Global Dermatophytic Onychomycosis Historic Market Size by Type (2016-2021)
4.2 Global Dermatophytic Onychomycosis Forecasted Market Size by Type (2022-2027)

5 Dermatophytic Onychomycosis Breakdown Data by Application
5.1 Global Dermatophytic Onychomycosis Historic Market Size by Application (2016-2021)
5.2 Global Dermatophytic Onychomycosis Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Dermatophytic Onychomycosis Market Size (2016-2027)
6.2 North America Dermatophytic Onychomycosis Market Size by Type
6.2.1 North America Dermatophytic Onychomycosis Market Size by Type (2016-2021)
6.2.2 North America Dermatophytic Onychomycosis Market Size by Type (2022-2027)
6.2.3 North America Dermatophytic Onychomycosis Market Size by Type (2016-2027)
6.3 North America Dermatophytic Onychomycosis Market Size by Application
6.3.1 North America Dermatophytic Onychomycosis Market Size by Application (2016-2021)
6.3.2 North America Dermatophytic Onychomycosis Market Size by Application (2022-2027)
6.3.3 North America Dermatophytic Onychomycosis Market Size by Application (2016-2027)
6.4 North America Dermatophytic Onychomycosis Market Size by Country
6.4.1 North America Dermatophytic Onychomycosis Market Size by Country (2016-2021)
6.4.2 North America Dermatophytic Onychomycosis Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Dermatophytic Onychomycosis Market Size (2016-2027)
7.2 Europe Dermatophytic Onychomycosis Market Size by Type
7.2.1 Europe Dermatophytic Onychomycosis Market Size by Type (2016-2021)
7.2.2 Europe Dermatophytic Onychomycosis Market Size by Type (2022-2027)
7.2.3 Europe Dermatophytic Onychomycosis Market Size by Type (2016-2027)
7.3 Europe Dermatophytic Onychomycosis Market Size by Application
7.3.1 Europe Dermatophytic Onychomycosis Market Size by Application (2016-2021)
7.3.2 Europe Dermatophytic Onychomycosis Market Size by Application (2022-2027)
7.3.3 Europe Dermatophytic Onychomycosis Market Size by Application (2016-2027)
7.4 Europe Dermatophytic Onychomycosis Market Size by Country
7.4.1 Europe Dermatophytic Onychomycosis Market Size by Country (2016-2021)
7.4.2 Europe Dermatophytic Onychomycosis Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Dermatophytic Onychomycosis Market Size (2016-2027)
8.2 Asia-Pacific Dermatophytic Onychomycosis Market Size by Type
8.2.1 Asia-Pacific Dermatophytic Onychomycosis Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Dermatophytic Onychomycosis Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Dermatophytic Onychomycosis Market Size by Type (2016-2027)
8.3 Asia-Pacific Dermatophytic Onychomycosis Market Size by Application
8.3.1 Asia-Pacific Dermatophytic Onychomycosis Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Dermatophytic Onychomycosis Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Dermatophytic Onychomycosis Market Size by Application (2016-2027)
8.4 Asia-Pacific Dermatophytic Onychomycosis Market Size by Region
8.4.1 Asia-Pacific Dermatophytic Onychomycosis Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Dermatophytic Onychomycosis Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Dermatophytic Onychomycosis Market Size (2016-2027)
9.2 Latin America Dermatophytic Onychomycosis Market Size by Type
9.2.1 Latin America Dermatophytic Onychomycosis Market Size by Type (2016-2021)
9.2.2 Latin America Dermatophytic Onychomycosis Market Size by Type (2022-2027)
9.2.3 Latin America Dermatophytic Onychomycosis Market Size by Type (2016-2027)
9.3 Latin America Dermatophytic Onychomycosis Market Size by Application
9.3.1 Latin America Dermatophytic Onychomycosis Market Size by Application (2016-2021)
9.3.2 Latin America Dermatophytic Onychomycosis Market Size by Application (2022-2027)
9.3.3 Latin America Dermatophytic Onychomycosis Market Size by Application (2016-2027)
9.4 Latin America Dermatophytic Onychomycosis Market Size by Country
9.4.1 Latin America Dermatophytic Onychomycosis Market Size by Country (2016-2021)
9.4.2 Latin America Dermatophytic Onychomycosis Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Dermatophytic Onychomycosis Market Size (2016-2027)
10.2 Middle East & Africa Dermatophytic Onychomycosis Market Size by Type
10.2.1 Middle East & Africa Dermatophytic Onychomycosis Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Dermatophytic Onychomycosis Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Dermatophytic Onychomycosis Market Size by Type (2016-2027)
10.3 Middle East & Africa Dermatophytic Onychomycosis Market Size by Application
10.3.1 Middle East & Africa Dermatophytic Onychomycosis Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Dermatophytic Onychomycosis Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Dermatophytic Onychomycosis Market Size by Application (2016-2027)
10.4 Middle East & Africa Dermatophytic Onychomycosis Market Size by Country
10.4.1 Middle East & Africa Dermatophytic Onychomycosis Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Dermatophytic Onychomycosis Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Johnson & Johnson
11.1.1 Johnson & Johnson Company Details
11.1.2 Johnson & Johnson Business Overview
11.1.3 Johnson & Johnson Dermatophytic Onychomycosis Introduction
11.1.4 Johnson & Johnson Revenue in Dermatophytic Onychomycosis Business (2016-2021)
11.1.5 Johnson & Johnson Recent Development
11.2 GSK
11.2.1 GSK Company Details
11.2.2 GSK Business Overview
11.2.3 GSK Dermatophytic Onychomycosis Introduction
11.2.4 GSK Revenue in Dermatophytic Onychomycosis Business (2016-2021)
11.2.5 GSK Recent Development
11.3 Novartis
11.3.1 Novartis Company Details
11.3.2 Novartis Business Overview
11.3.3 Novartis Dermatophytic Onychomycosis Introduction
11.3.4 Novartis Revenue in Dermatophytic Onychomycosis Business (2016-2021)
11.3.5 Novartis Recent Development
11.4 Pfizer
11.4.1 Pfizer Company Details
11.4.2 Pfizer Business Overview
11.4.3 Pfizer Dermatophytic Onychomycosis Introduction
11.4.4 Pfizer Revenue in Dermatophytic Onychomycosis Business (2016-2021)
11.4.5 Pfizer Recent Development
11.5 Bausch Health
11.5.1 Bausch Health Company Details
11.5.2 Bausch Health Business Overview
11.5.3 Bausch Health Dermatophytic Onychomycosis Introduction
11.5.4 Bausch Health Revenue in Dermatophytic Onychomycosis Business (2016-2021)
11.5.5 Bausch Health Recent Development
11.6 Kaken Pharmaceutical
11.6.1 Kaken Pharmaceutical Company Details
11.6.2 Kaken Pharmaceutical Business Overview
11.6.3 Kaken Pharmaceutical Dermatophytic Onychomycosis Introduction
11.6.4 Kaken Pharmaceutical Revenue in Dermatophytic Onychomycosis Business (2016-2021)
11.6.5 Kaken Pharmaceutical Recent Development
11.7 Galderma
11.7.1 Galderma Company Details
11.7.2 Galderma Business Overview
11.7.3 Galderma Dermatophytic Onychomycosis Introduction
11.7.4 Galderma Revenue in Dermatophytic Onychomycosis Business (2016-2021)
11.7.5 Galderma Recent Development
11.8 Sanofi
11.8.1 Sanofi Company Details
11.8.2 Sanofi Business Overview
11.8.3 Sanofi Dermatophytic Onychomycosis Introduction
11.8.4 Sanofi Revenue in Dermatophytic Onychomycosis Business (2016-2021)
11.8.5 Sanofi Recent Development
11.9 Allergan
11.9.1 Allergan Company Details
11.9.2 Allergan Business Overview
11.9.3 Allergan Dermatophytic Onychomycosis Introduction
11.9.4 Allergan Revenue in Dermatophytic Onychomycosis Business (2016-2021)
11.9.5 Allergan Recent Development
11.10 Merz Pharma
11.10.1 Merz Pharma Company Details
11.10.2 Merz Pharma Business Overview
11.10.3 Merz Pharma Dermatophytic Onychomycosis Introduction
11.10.4 Merz Pharma Revenue in Dermatophytic Onychomycosis Business (2016-2021)
11.10.5 Merz Pharma Recent Development
11.11 Xiuzheng Pharmaceutical
11.11.1 Xiuzheng Pharmaceutical Company Details
11.11.2 Xiuzheng Pharmaceutical Business Overview
11.11.3 Xiuzheng Pharmaceutical Dermatophytic Onychomycosis Introduction
11.11.4 Xiuzheng Pharmaceutical Revenue in Dermatophytic Onychomycosis Business (2016-2021)
11.11.5 Xiuzheng Pharmaceutical Recent Development
11.12 Letai
11.12.1 Letai Company Details
11.12.2 Letai Business Overview
11.12.3 Letai Dermatophytic Onychomycosis Introduction
11.12.4 Letai Revenue in Dermatophytic Onychomycosis Business (2016-2021)
11.12.5 Letai Recent Development
11.13 Qilu Pharmaceutical
11.13.1 Qilu Pharmaceutical Company Details
11.13.2 Qilu Pharmaceutical Business Overview
11.13.3 Qilu Pharmaceutical Dermatophytic Onychomycosis Introduction
11.13.4 Qilu Pharmaceutical Revenue in Dermatophytic Onychomycosis Business (2016-2021)
11.13.5 Qilu Pharmaceutical Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Dermatophytic Onychomycosis Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Oral Medicine
Table 3. Key Players of External Medicine
Table 4. Global Dermatophytic Onychomycosis Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Dermatophytic Onychomycosis Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Dermatophytic Onychomycosis Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Dermatophytic Onychomycosis Market Share by Regions (2016-2021)
Table 8. Global Dermatophytic Onychomycosis Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Dermatophytic Onychomycosis Market Share by Regions (2022-2027)
Table 10. Dermatophytic Onychomycosis Market Trends
Table 11. Dermatophytic Onychomycosis Market Drivers
Table 12. Dermatophytic Onychomycosis Market Challenges
Table 13. Dermatophytic Onychomycosis Market Restraints
Table 14. Global Dermatophytic Onychomycosis Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Dermatophytic Onychomycosis Market Share by Players (2016-2021)
Table 16. Global Top Dermatophytic Onychomycosis Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Dermatophytic Onychomycosis as of 2020)
Table 17. Ranking of Global Top Dermatophytic Onychomycosis Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Dermatophytic Onychomycosis Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Dermatophytic Onychomycosis Product Solution and Service
Table 21. Date of Enter into Dermatophytic Onychomycosis Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Dermatophytic Onychomycosis Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Dermatophytic Onychomycosis Revenue Market Share by Type (2016-2021)
Table 25. Global Dermatophytic Onychomycosis Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Dermatophytic Onychomycosis Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Dermatophytic Onychomycosis Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Dermatophytic Onychomycosis Revenue Market Share by Application (2016-2021)
Table 29. Global Dermatophytic Onychomycosis Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Dermatophytic Onychomycosis Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Dermatophytic Onychomycosis Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Dermatophytic Onychomycosis Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Dermatophytic Onychomycosis Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Dermatophytic Onychomycosis Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Dermatophytic Onychomycosis Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Dermatophytic Onychomycosis Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Dermatophytic Onychomycosis Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Dermatophytic Onychomycosis Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Dermatophytic Onychomycosis Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Dermatophytic Onychomycosis Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Dermatophytic Onychomycosis Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Dermatophytic Onychomycosis Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Dermatophytic Onychomycosis Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Dermatophytic Onychomycosis Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Dermatophytic Onychomycosis Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Dermatophytic Onychomycosis Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Dermatophytic Onychomycosis Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Dermatophytic Onychomycosis Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Dermatophytic Onychomycosis Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Dermatophytic Onychomycosis Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Dermatophytic Onychomycosis Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Dermatophytic Onychomycosis Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Dermatophytic Onychomycosis Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Dermatophytic Onychomycosis Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Dermatophytic Onychomycosis Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Dermatophytic Onychomycosis Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Dermatophytic Onychomycosis Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Dermatophytic Onychomycosis Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Dermatophytic Onychomycosis Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Dermatophytic Onychomycosis Market Size by Country (2022-2027) & (US$ Million)
Table 61. Johnson & Johnson Company Details
Table 62. Johnson & Johnson Business Overview
Table 63. Johnson & Johnson Dermatophytic Onychomycosis Product
Table 64. Johnson & Johnson Revenue in Dermatophytic Onychomycosis Business (2016-2021) & (US$ Million)
Table 65. Johnson & Johnson Recent Development
Table 66. GSK Company Details
Table 67. GSK Business Overview
Table 68. GSK Dermatophytic Onychomycosis Product
Table 69. GSK Revenue in Dermatophytic Onychomycosis Business (2016-2021) & (US$ Million)
Table 70. GSK Recent Development
Table 71. Novartis Company Details
Table 72. Novartis Business Overview
Table 73. Novartis Dermatophytic Onychomycosis Product
Table 74. Novartis Revenue in Dermatophytic Onychomycosis Business (2016-2021) & (US$ Million)
Table 75. Novartis Recent Development
Table 76. Pfizer Company Details
Table 77. Pfizer Business Overview
Table 78. Pfizer Dermatophytic Onychomycosis Product
Table 79. Pfizer Revenue in Dermatophytic Onychomycosis Business (2016-2021) & (US$ Million)
Table 80. Pfizer Recent Development
Table 81. Bausch Health Company Details
Table 82. Bausch Health Business Overview
Table 83. Bausch Health Dermatophytic Onychomycosis Product
Table 84. Bausch Health Revenue in Dermatophytic Onychomycosis Business (2016-2021) & (US$ Million)
Table 85. Bausch Health Recent Development
Table 86. Kaken Pharmaceutical Company Details
Table 87. Kaken Pharmaceutical Business Overview
Table 88. Kaken Pharmaceutical Dermatophytic Onychomycosis Product
Table 89. Kaken Pharmaceutical Revenue in Dermatophytic Onychomycosis Business (2016-2021) & (US$ Million)
Table 90. Kaken Pharmaceutical Recent Development
Table 91. Galderma Company Details
Table 92. Galderma Business Overview
Table 93. Galderma Dermatophytic Onychomycosis Product
Table 94. Galderma Revenue in Dermatophytic Onychomycosis Business (2016-2021) & (US$ Million)
Table 95. Galderma Recent Development
Table 96. Sanofi Company Details
Table 97. Sanofi Business Overview
Table 98. Sanofi Revenue in Dermatophytic Onychomycosis Business (2016-2021) & (US$ Million)
Table 99. Sanofi Recent Development
Table 100. Allergan Company Details
Table 101. Allergan Business Overview
Table 102. Allergan Dermatophytic Onychomycosis Product
Table 103. Allergan Revenue in Dermatophytic Onychomycosis Business (2016-2021) & (US$ Million)
Table 104. Allergan Recent Development
Table 105. Merz Pharma Company Details
Table 106. Merz Pharma Business Overview
Table 107. Merz Pharma Dermatophytic Onychomycosis Product
Table 108. Merz Pharma Revenue in Dermatophytic Onychomycosis Business (2016-2021) & (US$ Million)
Table 109. Merz Pharma Recent Development
Table 110. Xiuzheng Pharmaceutical Company Details
Table 111. Xiuzheng Pharmaceutical Business Overview
Table 112. Xiuzheng Pharmaceutical Dermatophytic Onychomycosis Product
Table 113. Xiuzheng Pharmaceutical Revenue in Dermatophytic Onychomycosis Business (2016-2021) & (US$ Million)
Table 114. Xiuzheng Pharmaceutical Recent Development
Table 115. Letai Company Details
Table 116. Letai Business Overview
Table 117. Letai Dermatophytic Onychomycosis Product
Table 118. Letai Revenue in Dermatophytic Onychomycosis Business (2016-2021) & (US$ Million)
Table 119. Letai Recent Development
Table 120. Qilu Pharmaceutical Company Details
Table 121. Qilu Pharmaceutical Business Overview
Table 122. Qilu Pharmaceutical Dermatophytic Onychomycosis Product
Table 123. Qilu Pharmaceutical Revenue in Dermatophytic Onychomycosis Business (2016-2021) & (US$ Million)
Table 124. Qilu Pharmaceutical Recent Development
Table 125. Research Programs/Design for This Report
Table 126. Key Data Information from Secondary Sources
Table 127. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Dermatophytic Onychomycosis Market Share by Type: 2020 VS 2027
Figure 2. Oral Medicine Features
Figure 3. External Medicine Features
Figure 4. Global Dermatophytic Onychomycosis Market Share by Application: 2020 VS 2027
Figure 5. Age Under 18 Case Studies
Figure 6. Age 18-50 Case Studies
Figure 7. Age Above 50 Case Studies
Figure 8. Dermatophytic Onychomycosis Report Years Considered
Figure 9. Global Dermatophytic Onychomycosis Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 10. Global Dermatophytic Onychomycosis Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Dermatophytic Onychomycosis Market Share by Regions: 2020 VS 2027
Figure 12. Global Dermatophytic Onychomycosis Market Share by Regions (2022-2027)
Figure 13. Global Dermatophytic Onychomycosis Market Share by Players in 2020
Figure 14. Global Top Dermatophytic Onychomycosis Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Dermatophytic Onychomycosis as of 2020
Figure 15. The Top 10 and 5 Players Market Share by Dermatophytic Onychomycosis Revenue in 2020
Figure 16. Global Dermatophytic Onychomycosis Revenue Market Share by Type (2016-2021)
Figure 17. Global Dermatophytic Onychomycosis Revenue Market Share by Type (2022-2027)
Figure 18. North America Dermatophytic Onychomycosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 19. North America Dermatophytic Onychomycosis Market Share by Type (2016-2027)
Figure 20. North America Dermatophytic Onychomycosis Market Share by Application (2016-2027)
Figure 21. North America Dermatophytic Onychomycosis Market Share by Country (2016-2027)
Figure 22. United States Dermatophytic Onychomycosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Canada Dermatophytic Onychomycosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Dermatophytic Onychomycosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Dermatophytic Onychomycosis Market Share by Type (2016-2027)
Figure 26. Europe Dermatophytic Onychomycosis Market Share by Application (2016-2027)
Figure 27. Europe Dermatophytic Onychomycosis Market Share by Country (2016-2027)
Figure 28. Germany Dermatophytic Onychomycosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. France Dermatophytic Onychomycosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. U.K. Dermatophytic Onychomycosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Italy Dermatophytic Onychomycosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Russia Dermatophytic Onychomycosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Nordic Dermatophytic Onychomycosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Dermatophytic Onychomycosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Dermatophytic Onychomycosis Market Share by Type (2016-2027)
Figure 36. Asia-Pacific Dermatophytic Onychomycosis Market Share by Application (2016-2027)
Figure 37. Asia-Pacific Dermatophytic Onychomycosis Market Share by Region (2016-2027)
Figure 38. China Dermatophytic Onychomycosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Japan Dermatophytic Onychomycosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. South Korea Dermatophytic Onychomycosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Southeast Asia Dermatophytic Onychomycosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. India Dermatophytic Onychomycosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Australia Dermatophytic Onychomycosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Dermatophytic Onychomycosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Dermatophytic Onychomycosis Market Share by Type (2016-2027)
Figure 46. Latin America Dermatophytic Onychomycosis Market Share by Application (2016-2027)
Figure 47. Latin America Dermatophytic Onychomycosis Market Share by Country (2016-2027)
Figure 48. Mexico Dermatophytic Onychomycosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Brazil Dermatophytic Onychomycosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Dermatophytic Onychomycosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Dermatophytic Onychomycosis Market Share by Type (2016-2027)
Figure 52. Middle East & Africa Dermatophytic Onychomycosis Market Share by Application (2016-2027)
Figure 53. Middle East & Africa Dermatophytic Onychomycosis Market Share by Country (2016-2027)
Figure 54. Turkey Dermatophytic Onychomycosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Saudi Arabia Dermatophytic Onychomycosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. UAE Dermatophytic Onychomycosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Johnson & Johnson Revenue Growth Rate in Dermatophytic Onychomycosis Business (2016-2021)
Figure 58. GSK Revenue Growth Rate in Dermatophytic Onychomycosis Business (2016-2021)
Figure 59. Novartis Revenue Growth Rate in Dermatophytic Onychomycosis Business (2016-2021)
Figure 60. Pfizer Revenue Growth Rate in Dermatophytic Onychomycosis Business (2016-2021)
Figure 61. Bausch Health Revenue Growth Rate in Dermatophytic Onychomycosis Business (2016-2021)
Figure 62. Kaken Pharmaceutical Revenue Growth Rate in Dermatophytic Onychomycosis Business (2016-2021)
Figure 63. Galderma Revenue Growth Rate in Dermatophytic Onychomycosis Business (2016-2021)
Figure 64. Sanofi Revenue Growth Rate in Dermatophytic Onychomycosis Business (2016-2021)
Figure 65. Allergan Revenue Growth Rate in Dermatophytic Onychomycosis Business (2016-2021)
Figure 66. Merz Pharma Revenue Growth Rate in Dermatophytic Onychomycosis Business (2016-2021)
Figure 67. Xiuzheng Pharmaceutical Revenue Growth Rate in Dermatophytic Onychomycosis Business (2016-2021)
Figure 68. Letai Revenue Growth Rate in Dermatophytic Onychomycosis Business (2016-2021)
Figure 69. Qilu Pharmaceutical Revenue Growth Rate in Dermatophytic Onychomycosis Business (2016-2021)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed

---